Try our Advanced Search for more refined results
Competition
-
January 28, 2026
Farmers Say 'Secret' Union Pacific Fee Blocks Rival Rail Line
Kansas and Colorado grain farmers and the company they use to ship their grain to the West Coast sued Union Pacific in Kansas federal court for allegedly using a "secret" fee illegally hidden from federal rail regulators to stop the plaintiffs from using a cheaper alternative rail line.
-
January 28, 2026
Casino License Revocation Order Off The Mark, 8th Circ. Told
Two Cherokee Nation entities say an Arkansas federal court "struck out on its own" when it dismissed claims over the revocation of an Arkansas-issued gambling license, telling the Eighth Circuit that the decision sets a dangerous precedent that will haunt the state as it seeks multimillion-dollar investors.
-
January 28, 2026
ArentFox Schiff Launches Longevity Industry Group
ArentFox Schiff LLP on Wednesday announced the launch of a group geared toward advising companies focused on advancing wellness, preventive health care and the longevity of life.
-
January 28, 2026
LegitScript's Counterclaims Against PharmacyChecker Tossed
An Oregon federal court dismissed LegitScript's counterclaims accusing PharmacyChecker.com of making false statements about the legality of importing prescription drugs, in a suit accusing the pharmacy accreditation provider of blacklisting the price-checking website.
-
January 28, 2026
Ropes & Gray Adds 3 Partners In New York
Ropes & Gray LLP has expanded its offerings in New York with the addition of three attorneys, one each from Debevoise, Paul Weiss and Wachtell Lipton.
-
January 28, 2026
Longtime DOJ Antitrust Litigator Joins Duane Morris
A veteran antitrust litigator at the U.S. Department of Justice left the federal government to join Duane Morris LLP as a partner, the firm has announced.
-
January 28, 2026
Fed. Circ. Won't Revive MasterCard Trade Secret Claims
The Federal Circuit declined to revive trade secret theft claims Wednesday brought by a MasterCard unit against two former McKinsey consultants, agreeing with a lower court that the company had failed to identify the alleged trade secrets with enough specificity.
-
January 28, 2026
Company Seeks Damages Despite Invalid Noncompetes
The Delaware Supreme Court on Wednesday probed how far employers can go in enforcing noncompete and nonsolicitation clauses tied to lucrative equity awards, pressing both sides in a dispute between Fortiline Inc. and Patriot Supply Holdings Inc. and a group of former executives on whether companies should be able to recover damages for alleged breaches even when lower courts have found the underlying restraints unenforceable.
-
January 28, 2026
NJ Atty Calls Fla. Bar's High Fees Unconstitutional
A New Jersey lawyer urged the Eleventh Circuit on Wednesday to revive his suit accusing the Florida Board of Bar Examiners of violating the dormant commerce clause by charging out-of-state attorneys disproportionately high fees to sit for the Florida bar exam.
-
January 28, 2026
Generics Makers Want Hospital Drug Data In Price-Fixing MDL
A group of 150 hospitals suing generic-drug makers for alleged price fixing in multidistrict litigation should hand over data on their drug purchases, the drugmakers have told a Pennsylvania federal court, arguing they don't sell directly to the hospitals and therefore have no records themselves.
-
January 28, 2026
Mich. Clears Way For High School Athletes To Earn NIL Money
High school athletes in Michigan will now be allowed to profit off their name, image and likeness after state authorities unveiled a policy change to expand and emphasize "personal branding activities" for students.
-
January 28, 2026
Top German Court Rejects Antitrust FRAND Challenge
Germany's top civil court has ruled that a patent holder has not breached European Union antitrust laws by seeking an injunction against a mobile phone company amid the pair's failure to negotiate a license agreement on FRAND terms.
-
January 27, 2026
Ohio PBM Suit Belongs In Federal Court, 6th Circ. Rules
The Sixth Circuit on Tuesday ruled that Ohio's lawsuit accusing pharmacy benefit managers of driving up prescription prices through rebate schemes belongs in federal court, saying in an opinion recommended for publication that the suit imposes liability on conduct undertaken at the direction of a federal officer.
-
January 27, 2026
Google's Allegedly Stolen AI Secrets Not Valuable, Jury Told
Former Google engineer Linwei Ding's counsel wrapped his defense case Tuesday, questioning a technical expert who told a California federal jury that the documents taken by Ding related to artificial intelligence supercomputers wouldn't allow someone to replicate Google's technology and had minimal value to competitors.
-
January 27, 2026
Iowa Can't Block Schwab's Antitrust Deal, 5th Circ. Told
A group of investors who settled with The Charles Schwab Corp. in an antitrust suit over the financial services company's merger with TD Ameritrade has urged the Fifth Circuit to dismiss an appeal filed by the state of Iowa, which had previously objected to the settlement's lack of monetary benefit to the class and proposed attorney payouts.
-
January 27, 2026
Medtronic Rival's VP Says Docs Praised Device But Didn't Buy
A vice president in charge of sales at Applied Medical testified Tuesday in a California federal trial over his company's antitrust claims against Medtronic, and said the overwhelmingly positive feedback Applied received from surgeons who used its advanced bipolar devices often didn't result in sales.
-
February 12, 2026
Law360 Seeks Members For Its 2026 Editorial Boards
Law360 is looking for avid readers of our publications to serve as members of our 2026 editorial advisory boards.
-
January 27, 2026
NCAA Warns Of Broad Impacts In WVU Players' Eligibility Row
If a West Virginia federal court's decision to give four football players another year of eligibility is left standing, scores of student-athletes will be emboldened to use last-minute litigation to skirt National Collegiate Athletic Association rules and secure more playing time, the NCAA's counsel told the Fourth Circuit on Tuesday.
-
January 27, 2026
Investors Say Teva Can't Get Early Win In Price-Fixing Suit
Investors guided by Highfields Capital told a Connecticut federal court that Teva Pharmaceuticals can't escape their claims that its alleged collusion with other drugmakers to artificially inflate the price of generic drugs also inflated stock prices, reasoning that Teva executives falsely attributed the company's performance to factors other than the alleged price-fixing.
-
January 27, 2026
Adhesive Cos. Push Back On FTC Merger Concerns
The makers of Loctite and Liquid Nails told a New York federal court that the Federal Trade Commission will be unable to show their planned $725 million merger will hurt competition for construction adhesives.
-
January 27, 2026
Apple Accused Of Stealing Webcam Functionality For IPhones
Apple was sued Tuesday by a company claiming it was induced into developing technology allowing for high-fidelity imaging in a smartphone that Apple then stole for use in iPhones.
-
January 27, 2026
Mylan's Sanofi Insulin Suit Mostly Survives Dismissal Bid
A Pennsylvania federal judge Tuesday largely refused to dismiss Mylan Pharmaceuticals' antitrust lawsuit accusing Sanofi of unlawfully maintaining a monopoly in the market for injectable insulin glargine.
-
January 27, 2026
AGs' HPE-Juniper Hold Too Broad, Too Late, Judge Says
A California federal judge explained his reasoning for refusing to block further integration between Hewlett Packard Enterprise and Juniper Networks, while Democratic attorneys general challenge the Justice Department's controversial settlement permitting the merger.
-
January 27, 2026
Colo. Atty Says Former Mentee Poached Clients
A Colorado attorney told a state court that a former associate he mentored for several years secretly solicited firm clients, misused confidential information and set up a competing practice while still employed.
-
January 27, 2026
Homebuyers Say Rocket Mortgage Illegally Inflated Prices
A proposed class of homebuyers accused Rocket Companies Inc. and its subsidiaries in Michigan federal court of illegally hiking home prices by sending business leads to real estate agents who pushed clients to use Rocket's "disadvantageous" financing services for purchases.
Expert Analysis
-
Associates Can Earn Credibility By Investing In Relationships
As the class of 2025 prepares to join law firms this fall, new associates must adapt to office dynamics and establish credible reputations — which require quiet, consistent relationship-building skills as much as legal acumen, says Kyle Forges at Bast Amron.
-
Opinion
The Fallout Of Drake's Defamation Suit Against UMG
Hip-hop duo Clipse's recent comeback was caught in the undertow of the ongoing Drake v. Universal Music Group defamation litigation, which points to the troubling possibility that if labels can be held liable for promoting allegedly defamatory lyrics, they may preemptively sanitize content to avoid lawsuits, says Henry Williams IV at Gordon Rees.
-
Filing Clarifies FTC, DOJ's Passive Investment Stance
The antitrust agencies' statement of interest filed in Texas v. Blackrock clarifies that certain forms of corporate governance engagement are permissible under the "solely for investment" exemption, a move that offers guidance for passive investors but also signals new scrutiny of coordinated engagement, say attorneys at Stinson.
-
Lessons From 7th Circ.'s Deleted Chat Sanctions Ruling
The Seventh Circuit’s recent decision in Pable v. Chicago Transit Authority, affirming the dismissal of an ex-employee’s retaliation claims, highlights the importance of properly handling the preservation of ephemeral messages and clarifies key sanctions issues, says Philip Favro at Favro Law.
-
Opinion
Sometimes Int'l Competition Should Trump Antitrust Concerns
The U.S. Justice Department's approval of HPE's $14 billion acquisition of Juniper Networks shows that a merger that significantly enhances innovation and competitiveness may serve consumer and national interests despite marginally increasing industry concentration, says John Reeves at Reeves Law.
-
Series
Quilting Makes Me A Better Lawyer
Turning intricate patterns of fabric and thread into quilts has taught me that craftsmanship, creative problem-solving and dedication to incremental progress are essential to creating something lasting that will help another person — just like in law, says Veronica McMillan at Kramon & Graham.
-
A Look At Robinson-Patman Enforcement In The MLM Industry
The Federal Trade Commission's recent focus on price discrimination in high-profile speeches and litigation suggests a renewed interest around Robinson-Patman Act enforcement, particularly in multilevel marketing, making it an apt time for direct sellers to audit their pricing, say Katrina Eash at Winston & Strawn and Juliet Belling Warren and Branko Jovanovic at Edgeworth Economics.
-
What 2 Profs Noticed As Transactional Law Students Used AI
After a semester using generative artificial intelligence tools with students in an entrepreneurship law clinic, we came away with numerous observations about the opportunities and challenges such tools present to new transactional lawyers, say professors at Cornell Law School.
-
State AGs Are Turning Up The Antitrust Heat On ESG Actions
Recent antitrust developments from red state attorneys general continue a trend of environmental, social and governance scrutiny, and businesses exposed to these areas should conduct close examinations of strategy and potential material risk, say attorneys at Morgan Lewis.
-
Rebuttal
BigLaw Settlements Should Not Spur Ethics Deregulation
A recent Law360 op-ed argued that loosening law firm funding restrictions would make BigLaw firms less inclined to settle with the Trump administration, but deregulating legal financing ethics may well prove to be not merely ineffective, but counterproductive, says Laurel Kilgour at the American Economic Liberties Project.
-
Opinion
8th Circ. Should Reaffirm False Commercial Speech's Nature
The Eighth Circuit in Goldfinch Laboratory v. Iowa Pathology Associates should assert that false commercial speech is not categorically immune from antitrust scrutiny, says Daniel Graulich at the Federal Trade Commission.
-
How Big Pharma Has Responded To FTC Delisting Demands
Looking at some statistics concerning how pharmaceutical companies have responded to the Federal Trade Commission's recent challenges to Orange Book listings raises several possible hypotheses about the FTC's strategy and effectiveness, say Ratib Ali and Celia Lu at Competition Dynamics.
-
Unpacking Ore. Law's Limits On PE Healthcare Investment
A recent Oregon law imposes significant restrictions on nonphysicians owning or controlling medical practices, but newly enacted amendments provide some additional flexibility in certain ownership arrangements without scuttling the law's intent of addressing concerns about the rise of private equity investment in healthcare, say attorneys at Debevoise.
-
5 Ways Lawyers Can Earn Back The Public's Trust
Amid salacious headlines about lawyers behaving badly and recent polls showing the public’s increasingly unfavorable view of attorneys, we must make meaningful changes to our culture to rebuild trust in the legal system, says Carl Taylor at Carl Taylor Law.
-
Class Actions At The Circuit Courts: August Lessons
In this month's review of class action appeals, Mitchell Engel at Shook Hardy discusses key takeaways from federal appellate decisions involving topics including antitrust, immigration, consumer fraud, birthright citizenship under the Fourteenth Amendment, and product defects.